Hauptseite > Workflowsammlungen > Publikationsgebühren > Solution-Based Determination of Dissociation Constants for the Binding of Aβ42 to Antibodies > print

001     864099
005     20230223075109.0
024 7 _ |a 10.1002/open.201900167
|2 doi
024 7 _ |a 2191-1355
|2 ISSN
024 7 _ |a 2191-1363
|2 ISSN
024 7 _ |a 2128/22715
|2 Handle
024 7 _ |a altmetric:63919469
|2 altmetric
024 7 _ |a pmid:31367507
|2 pmid
024 7 _ |a WOS:000477965100019
|2 WOS
037 _ _ |a FZJ-2019-04002
082 _ _ |a 540
100 1 _ |a Zhang, Tao
|0 P:(DE-Juel1)177882
|b 0
245 _ _ |a Solution-Based Determination of Dissociation Constants for the Binding of Aβ42 to Antibodies
260 _ _ |a Weinheim
|c 2019
|b Wiley-VCH-Verl.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1583144379_31665
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Amyloid β‐peptides (Aβ) play a major role in the pathogenesis of Alzheimer's disease. Therefore, numerous monoclonal antibodies against Aβ have been developed for basic and clinical research. The present study applied fluorescence based analytical ultracentrifugation and microscale thermophoresis to characterize the interaction between Aβ42 monomers and three popular, commercially available antibodies, namely 6E10, 4G8 and 12F4. Both methods allowed us to analyze the interactions at low nanomolar concentrations of analytes close to their dissociation constants (KD) as required for the study of high affinity interactions. Furthermore, the low concentrations minimized the unwanted self‐aggregation of Aβ. Our study demonstrates that all three antibodies bind to Aβ42 monomers with comparable affinities in the low nanomolar range. KD values for Aβ42 binding to 6E10 and 4G8 are in good agreement with formerly reported values from SPR studies, while the KD for 12F4 binding to Aβ42 monomer is reported for the first time.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Nagel-Steger, Luitgard
|0 P:(DE-Juel1)162443
|b 1
|e Corresponding author
700 1 _ |a Willbold, Dieter
|0 P:(DE-Juel1)132029
|b 2
773 _ _ |a 10.1002/open.201900167
|g Vol. 8, no. 7, p. 989 - 994
|0 PERI:(DE-600)2655605-4
|n 7
|p 989 - 994
|t ChemistryOpen
|v 8
|y 2019
|x 2191-1363
856 4 _ |u https://juser.fz-juelich.de/record/864099/files/Rechnung_R-2019-00444.pdf
856 4 _ |u https://juser.fz-juelich.de/record/864099/files/Zhang_et_al-2019-ChemistryOpen.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/864099/files/Zhang_et_al-2019-ChemistryOpen.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/864099/files/Rechnung_R-2019-00444.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:juser.fz-juelich.de:864099
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)177882
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)162443
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)132029
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CHEMISTRYOPEN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 p c |a DFG OA Publikationskosten
|2 APC
|0 PC:(DE-HGF)0002
915 p c |a DOAJ Journal
|2 APC
|0 PC:(DE-HGF)0003
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 1 _ |a APC
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a APC
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21